Provocation tests with allergens
1997; Wiley; Volume: 52; Issue: s35 Linguagem: Inglês
10.1111/j.1398-9995.1997.tb04814.x
ISSN1398-9995
AutoresG Melillo, С. Бонини, Giulio Cocco, Robert J.O. Davies, J. G. R. de Monchy, L. Frelund, Z Pelikán,
Tópico(s)Inhalation and Respiratory Drug Delivery
ResumoAllergyVolume 52, Issue s35 p. 5-35 Provocation tests with allergens G. Melillo, G. MelilloSearch for more papers by this authorS. Bonini, S. BoniniSearch for more papers by this authorG. Cocco, G. CoccoSearch for more papers by this authorR. J. Davies, R. J. DaviesSearch for more papers by this authorJ. G. R. de Monchy, J. G. R. de MonchySearch for more papers by this authorL. Frelund, L. FrelundSearch for more papers by this authorZ. Pelikan, Z. PelikanSearch for more papers by this author G. Melillo, G. MelilloSearch for more papers by this authorS. Bonini, S. BoniniSearch for more papers by this authorG. Cocco, G. CoccoSearch for more papers by this authorR. J. Davies, R. J. DaviesSearch for more papers by this authorJ. G. R. de Monchy, J. G. R. de MonchySearch for more papers by this authorL. Frelund, L. FrelundSearch for more papers by this authorZ. Pelikan, Z. PelikanSearch for more papers by this author First published: 30 December 2008 https://doi.org/10.1111/j.1398-9995.1997.tb04814.xCitations: 65AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Chai H, Farr RS, Froehlich LA et al. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975; 50: 323. 2 Aas K. The bronchial provocation test. Springfield, IL Charles C. Thomas, 1975. 3 Spector SL. Provocative challenge procedures. Vol. 1. Boca Raton, FL: CRC Press, 1983. 4 Davies RJ, Morgan DJR, Osman J et al. Bronchial provocation tests. In: JW Kerr, MA Gouderton, ed. Proc XI Int Cong Allergol Clin Immunol, London 17–22 Oct. 1982; London: Macmillan Press, 1983: 213. 5 Spector SL. Physiologic changes that occur in response to allergen induced challenge. Clin Rev Allergy 1985; 3: 463. 6 Debelic M, Radelovíc P Tests de provocation bronchiques aux allergènes dans le diagnostic de l'asthma bronchique. Série sur 1′Asthma 11. Basle: Sandoz, 1986. 7 Debelic M. Bronchial provocation tests with allergens in clinical practice. In: G Memo, P Norman, G Marone, ed. Respiratory allergy. Clinical immunology, Vol. 2. Toronto: B.C. Decker, 1990: 233. 8 Pauli G. Les tests de provocation bronchique specifiques. Prax-Klin Pneumol 1988; 42: 278. 9 Mausmann HC. Allergy tests in clinical diagnosis. In: CW Bierman, DS Pearlman, ed. Allergic diseases of infancy, childhood and adolescence. Philadelphia: W.B. Sanders Co., 1980: 289. 10 Michel FB, Godard P, Bousquet J et al. Evaluation of allergenic challenge in diagnosis of allergic asthma and antiasthma drugs research. J Aerosol Med 1991; 4 (suppl 1): 61. 11 Spector SL, Fazz RS. Bronchial inhalation procedures in asthmatics. Med Clin North Am 1974; 58: 71. 12 Mosbech H et al. House dust mite asthma. Correlation between allergen sensitivity in various organs. Allergy 1987; 42: 456. 13 Huggins KG, Brostoff J. Local production of specific IgE antibodies in allergic rhinitis with negative skin tests. Lancet 1975; ii: 148. 14 Malling HJ, Weeke B. Position paper: immunotherapy. Allergy 1993; 14(suppl 48): 9. 15 Rosenthal RR. Inhalation challenge. In: G Melillo, PS Norman, G Marone, ed. Respiratory allergy. Toronto: B.C. Decker, 1990: 1930. 16 Pelikan Z, Pelikan M. Early and late asthmatic response to allergen challenge and their pharmacological modulation. Ann Allergy 1985; 55: 318 (Abstr 372). 17 Melillo G, Cocco G. Bronchial challenge in pollen asthma. In: P Falagiani, ed. Pollinosis, Boca Raton, FL: CRC Press, 1990: 153. 18 Liejens HJT, Degenhart HS, Ruatgeep HE et al. Study on the significance of bronchial hyperreactivity in the bronchus obstruction after inhalation of cat induced dander allergen. J Allergy Clin Immunol 1979; 54: 507. 19 Schultze-Werninghouse G, Levy J, Bergman EM et al. Clinical significance of airborne Alternaria spores: tenuis sysonal symptoms, positive skin and bronchial challenge tests with Ahernaria in subjects asthma and rhinitis. Experientia 1987:suppl 51: 153. 20 Pelikan Z, Pelikan-Filipek M. Isolated and dual type of late asthmatic response, the clinical feature and pharmacological control. J Allergy Clin Immunol 1989; 83: 210 (Abstr 153). 21 Lopez M, Voigtlander JR, Lehr SB, Salvaggio JE. Broncho-provocation studies in basic studies in Basidio spore-sensitive subjects with asthma. J Allergy Clin Immunol 1989; 84: 242. 22 Daza JC, Aviles C, Arenas AS. Development of a protocol for application of the Alternaria specific bronchial provocation test to children (Abst.). Schweiz Med Wochenschr 1991:Suppl 40/II, 69. 23 Novembre E, Marano E, Bernardini R et al. The hazard of persistent reactions after bronchial provocation tests with Alternaria in children (Abst.). Schweiz Med Wochenschr 1991:Suppl. 40/II, 69. 24 Ingram CG, Jeffrey IG, Symingston IS et al. Bronchial provocation studies in farmers allergic to storage mites. Lancet 1979; ii: 1330. 25 Van Hage, Austen M, Ihre E et al. Bronchial provocation studies in farmers with positive RAST to the storage with Lepidogly. 26 Pola J, Valdiviero R, Zapata C et al. Specific bronchial challenge in cockroach asthma. Allergol Immunopathol 1988; 16: 171. 27 Kong BL, Johnson J, Morgan C et al. The role of immunotherapy in cockroach asthma. J Asthma 1988; 25: 218. 28 Bruce CA, Rosenthal RR, Lichtenstein LM, Norman PS. Quantitative inhalation bronchial challenge in ragweed hay fever patients: a comparison with ragweed allergic asthmatics. J Allergy Clin Immunol 1975; 56: 331. 29 Permut S, Rosenthal RR, Norman PS, Menkes HA. Bronchial challenge in ragweed sensitive patients. In: LM Lichtenstien, KF Austen, ed. Asthma, physiology, immunopharmacology and treatment. New York Academic Press, 1977. 30 Aas K. Discussion. In: LM Lichtenstein, KF Austen, ed. Asthma, physiology, immunopharmacology and treatment. New York: Academic Press, 1977: 277. 31 Melillo G. Allergen inhalation challenge with a micronized freeze-dried extract administered by a powder inhaler. In: G Melillo, PS Norman, G Marone, ed. Respiratory allergy. Clinical immunology. Vol. 2, Toronto: BC Decker, 1990: 207. 32 Lowagen O, Lindholm NB. Standardized provocation tests. J Allergy 1980; 35: 349. 33 Fralund L, Madsen F, Svendsen UG et al. Reproducibility of standardized provocation tests. Allergy 1986; 30: 41. 34 Kopperschmitt HC, Bigot H, Pauli G. Allergen bronchial challenge tests. Variability and reproducibility of the early response. J Allergy Clin Immunol 1987; 57: 30. 35 Melillo G, Aas K, Cartier A et al. Guidelines for the standardization of bronchial provocation tests with allergens. Allergy 1991; 46: 321. 36 Dreborg S. Skin prick test. An update. G Ital Allergol Immunol Clin 1988; 3: 35. 37 Aas K. Adequate clinical trial of immunotherapy. Allergy 1982; 37: 1. 38 Warner JO, Price JF, Soothil IF et al. Controlled trial of hyposensitization to Dermatophaigodes pteronyssinus in children with asthma. Lancet 1978; 29: 12. 39 Norman PS. Challenge techniques in the evaluation of immunotherapy. In: CE Reed ed. Proc III Int Congr Allergy Clin Immunol. St. Louis: Mosby, 1985: 319. 40 Swineford O et al. Tkeatment of pollen hay fever and asthma with aerosols of pollen extracts. J Allergy 1955; 26: 305. 41 McAllen MK. Bronchial sensitivity testing in asthma: an assessment of the effect of hyposensitization in house dust and pollen sensitivity asthmatics. Thorax 1961; 10: 16. 42 McAllen MK, Heag PS, Mcinoy P. Depot grass pollen injections in asthma. Effect of repeated treatment on clinical responses and measured bronchial sensitivity. Br Med J 1967; 1: 22. 43 Thlhida M et al. Effect of immunotherapy in chronic asthmatic children. J Allergy Clin Immunol 1973; 5: 1311. 44 Taylor WW et al. Immunotherapy in cat-induced asthma. Double blind trial with evaluation of bronchial responses to cat allergen and histamine. J Allergy Clin Immunol 1978; 283. 45 Valvistar E et al. Immunotherapy in allergy to dog: a double blind clinical study. Ann Allergy 1984; 53: 85. 46 Ohman JL, Fiidlay SA, Leiterman KM. Immunotherapy in cat-induced asthma. Double blind trial with evaluation of in vivo and in vitro responses. J Allergy Clin Immunol 1984; 74: 230. 47 Wahn U, Schwater C, Lind P et al. Prospective study on immunologic changes induced by two different Dermataphagoides pteronyssinus extracts prepared from whole mite culture and mite bodies. J Allergy Clin Immunol 1988; 82: 360. 48 Aas K. Hyposensitization in house dust allergic asthma. A double blind controlled study with evaluation of the effect in bronchial sensitivity to house dust. Acta Paediatr Scand 1972; 60: 264. 49 Hongard L, Dahl R. A controlled dose-response study of immunotherapy with standardized, partially purified extract of house dust mite: clinical efficacy and side effects. J Allergy Clin Immunol 1993; 91: 709. 50 Melillo G. Local immunotherapy by inhalation of allergic asthma. Preliminary results of a multi-center study. In: G Melillo, G Cocco, G Centanni ed. Proc XIII Cong EAACI, Budapest, 1986. The use of allergen in powder form for provocation tests and for local immunotherapy in allergic asthma. Naples: Publ. Forum Editorial, 1986. 51 Warner JD, Price JF, Southill JF et al. Controlled trial of hyphosensitization to Dermatophagoides pteronyssinus in children with asthma. Lancet 1978; 2: 912. 52 Metzer WJ, Donald BA, Richardson HB. Modification of late responses during immunotherapy for Alternaria-induced asthma. (Abstr) J Allergy Clin Immunol 1983; 71: 119. 53 Gleich GI. The late phase of the immunoglobulin E-mediated reaction: a link between anaphylaxis and common allergic disease. J Allergy Clin Immunol 1982; 70: 160. 54 Kaliner M. Hypotheses on the contribution of late phase allergic response to the understanding and treatment of allergic disease. J Allergy Clin Immunol 1984; 73: 311. 55 Lichtenstein LM, Valentine MD, Norman PS. A reevalu-ation of immunotherapy for asthma. Allergy Rev Respir 1984; 129: 657. 56 Maestrelli P, Boschetto P. Inhibition of allergen induced late asthmatic reaction after local immunotherapy with inhaled extract of Dennatophagoides pteronyssinus. Proc XIII Cong EAACI, Budapest 1986. In: G Melillo, G Cocco, G. Centanni ed. The use of allergen in powder form for provocation tests and for local immunotherapy in allergic asthma. Naples: Forum Ed, 1986: 100. 57 Van Bever HP, Stevens WJ. Suppression of late asthmatic reaction by hyposensitization in asthmatic children allergic to house dust mite. Clin Exp Allergy 1989; 19: 399. 58 Van Bever HP, Stevens WJ. Evolution of the late asthmatic reaction during immunotherapy and after stopping immunotherapy. J Allergy Clin Immunol 1990; 141. 59 Shampain MP, Behrens RL, Larsen GL et al. An animal model of late pulmonary responses to Alternuria challenge. Am Rev Respir Dis 1982; 126: 493. 60 Behrnus L, Clark RAF, Marsh W et al. Modulation of late asthmatic response by antigen specific immunoglobulin in animal models. Am Rev Respir Dis 1984; 130: 1134. 61 Cairns H. Models for the development of antiasthmatic drugs. In: J Pepys, MM Edwards eds The mast cell its role in health and disease. London: Pitman Publishers, 1979: 172. 62 Lichtenstein LM, Margolis S. Histamine release in vitro: inhibition by catecholamine and methylxathines. Science 1968; 902: 161. 63 Ishizaka I, Ishizaka K, Orange RP, Austen KE Pharma-cologic inhibition of the antigen-induced release of hista-mines and slow-reacting substance of anaphylaxis (SRS-A) from monkey lung tissues mediated by human IgE. J Immunol 1971; 106: 1267. 64 Bonn HR, Lichtenstein LM, Melmon KL. Pharmacologic control of allergic histamine release in vitro: evidence for an inhibitory role of 3′, 5′ adenosine monophosphate in human leucocytes. J Immunol 1972; 100: 695. 65 Church MK, Hiroi J. Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by antiallergic drugs and salbutamol. Br J Pharmacol 1987; 90: 421. 66 Kran J, Koëter GH, Van ver Mark TW et al. Change in bronchial hyperreactivity induced by 4 week treatment with anti-asthmatic drugs in allergic asthmatic patients: a comparison between budesonide and terbutaline. J Allergy Clin Immunol 1985; 76: 628. 67 Kerrebijn KF, Van Essen Zanduliet EEM, Nagens HJ. Effects of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma. J Allergy Clin Immunol 1987; 79: 635. 68 Skidmore IE Beta-agonists as mast-cell stabilizers In: AB Kay, ed. Asthma: clinical, pharmacology and therapeutic progress. London: Blackwell Scientific Publishers, 1980: 171. 69 Fish JE, Newball HH, Lenfant C. In vivo immuno pharmacology of the lung. In: HH Newball, ed. Immunopharma-cology of the lung. New York: Marcel Dekker, 1983: 273. 70 Hutchcroft B. Discussion. In: LM Lichtenstein, KF Austen, ed. Asthma, Physiology, immunopharmacology and treatment. New York: Academic Press, 1977: 14. 71 Bryant DH, Bums MW. Bronchial histamine reactivity: its relationship to the reactivity of the bronchi to allergens. Clin Allergy 1976; 6: 523. 72 Killian D, Cockcroft DW, Hargreave FE, Dolovich J. Factors in allergen-induced asthma: relevance of intensity of the airways allergic reaction and non specific bronchial reactivity. Clin Allergy 1976; 6: 219. 73 Cockcroft DW, Duffin RE, Frith GA et al. Determinants of allergen-induced asthma: dose of allergen, circulating IgE antibody concentration and bronchial responsiveness to inhaled histamine. Am Rev Respir Dis 1979; 120: 1053. 74 Melillo G, Cocco G, Schiano M, Balzano G. Relationship between atopy and non-specific bronchial hyperrespon-siveness in asthma. In: D Olivieri, S Bianco, ed. Airway obstruction and inflammation. Prog Respir Dis Basel: Karger, 1990: 151. 1 Aas K, Backmann A, Belin L, Weeke B. Standardization of allergen extracts with appropriate methods. The combined use of skin prick testing and radioallergosorbent test. Allergy 1978; 33: 130– 37. 2 Belin L. Standardized extracts, trees. Clin Rev Allergy 1986; 4: 389– 404. 3 IC. Bernstein ed. Report of the American Academy of Allergy Immunology task force on guidelines for clinical investigation of non-bronchodilator anti-asthmatic drugs. J Allergy Clin Immunol 1986; 78: 489– 546. 4 Cockcroft DW, Murdock KY, Kirby J, Hargreave F. Prediction of airway responsiveness to allergen from skin sensitivity to allergen and airway responsiveness to hista-mine. Am Rev Respir Dis 1987; 135: 264– 67. 5 Dreborg S. The skin prick test. Methodological studies and clinical applications. Medical Dissertation 239, Linkoping University 1987. 6 Frølund L, Madsen F, Svendsen UG, Nielsen NH, Weeke B. Reproducibility of responsiveness to a standardized bronchial allergen provocation. R, compared to FEV, as measurement of response to provocation. Clin Allergy 1987; 17: 217– 28. 7 Frølund L, Poulsen LK, Heinig JH, Svendsen UG, Madsen F. Immunological and physical properties of allergen solutions. Effects of nebulization. Allergy 1991; 46: 1– 9. 8 Løwenstein H, Lind P, Billesbølle K. Immunochemical methods for source materials. Arb Paul Ehrlich Inst 1978; 78: 141– 47. 9 Løwenstein H. Physico-chemical and immunochemical methods for the control and quality of allergenic extracts. In: First Int Paul Ehrlich Seminar. Stuttgart: Gustav Fisher Verlag, 1980; 79: 122. 10 Løwenstein H. Report on behalf of the International Union of Immunological Societies (IUIS) Allergen Standardization Subcommittee. Arb Paul Ehrlich Inst 1983; 78: 41– 48. 11 Matthiesen F. Standardization of allergenic extracts. Z Hautkrh 1988; 63(suppl 4): 542– 54. 12 Melillo G. Allergen inhalation challenge with a micronized freeze dried extract administered by a powder inhaler. In: G Melillo, PS Norman, G Marone eds. Respiratory allergy. Toronto: BC Decker, 1990: 207– 214. 13 Nordic Council of Medicines. Registration of allergen preparations. Nordic guidelines. Uppsala: NLN, publication no. 7, 1982. 14 Nordic Council of Medicines. Common Nordic guidelines for registration of allergenic preparations. 2nd edn. Uppsala: NLN, 1989: 23. 15 Norman PS. International units. In: R Kurth, ed. Regulatory control and standardization of allergenic extracts. Proceedings from Fiith Int Paul Ehrlich Seminar. Stuttgart: Gustav Fisher Verlag, 1987: 175– 82. 16 Rosenthal R, Lassen A, Jacobsen L, Svendsen UG. Trends in the use of specific immunotherapy. In: Przybilla Ring, ed. New trends in allergy III. Berlin: Springer Verlag, 1991. 17 Ihrkeltaub PC. Assignment of bioequivalent allergy units based on biological standardization of allergenic extracts. Proceedings from Fifth International Paul Ehrlich Seminar. Stuttgart: Gustav Fisher Verlag, 1987: 19– 40. 18 Turkeltaub PC, Rastogi SC, Baer H, Anderson MC, Norman PS. A standardized quantitative skin test assay of allergen potency and stability: studies on the allergen dose-response curve and effect of wheal, erythema, and patient selection on assay results. J Allergy Clin Immunol 1982; 70: 343– 52. 19 Turkeltaub PC, Campbell G, Mosimann JE. Comparative safety and efficacy of short ragweed extracts differing in potency and composition in the treatment of fall hay fever. Allergy 1990; 45: 528– 46. 20 Varney VA, Gaga M, Frew AJ, Aber VR, Kay AB, Durham SR. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. Br Med J 1991; 302: 265– 69. 21 WHO Expert Committee on Biological Standardization. Guidelines for the preparation and establishment of reference materials and reference reagents for biological substances. WHO Tech Rep Series 1978: 626. 1 Cockcroft D, Ruffin R, Dolowcch J, Hargreave E Allergen-induced increase in non-allergic bronchial reactivity. Clin Allergy 1977; 7: 503– 513. 2 MacIntyre D, Boyd G. Factors influencing the occurrence of a late reaction to allergen challenge in atopic asthmatics. Clin Allergy 1984; 14: 311– 317. 3 de Monchy JGR, Kauffman HF, Venge P et al. Broncho-alveolair eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis 1985; 131: 373– 6. 4 Beasly R, Roche W, Roberts J, Holgate S. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989; 139: 806– 817. 5 Busse W, Calhoun W, Sedgwick J. Mechanism of airway inflammation in asthma. Am Rev Respir Dis 1993; 147: s20– s24. 6 Frew AJ, Corrigan CJ, Maestrelli P et al. T lymphocytes in allergen-induced late-phase reactions and asthma. Int Arch Allergy Appl Immunol 1989; 88(1–2): 63– 67. 7 Kay AB. Asthma and inflammation. J Allergy Clin Immunol 1991; 87: 893– 910. 8 Hsieh K. Altered interleukin-2 (IL2) production and responsiveness after hyposensitization to house dust. J Allergy Clin Immunol 1985; 76: 188– 94. 9 Van Bever H, Stevens W. Frequency and intensity of late asthmatic reactions after a bronchial challenge in asthma and rhinitis. Allergy 1989; 44: 471– 476. 10 de Monchy JGR, Kauffman HF, Venge P et al. Broncho-alveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis 1985; 131: 373. 11 Frolund L, Bonini S, Cocco G et al. Allergen extracts. Standardization of preparation for bronchial provocation tests. A position paper. Clin Exp Allergy 1993; 23: 702– 708. 12 Melillo G. Allergen inhalation challenge with a micronized freeze fried extract administered by a powder inhaler. In: Respiratory allergy. Clinical immunology. V. Z. Melillo, PS Norman, G Marone, ed. New York: M. Dekker, 1990; 23: 207– 213. 13 Ryan G, Dolovich MB, Obminski G et al. Standardization of inhalation tests: influence of nebulizer output, particle size and method of inhalation. J Allergy Clin Immunol 1981; 67: 156– 161. 14 Cockroft DW, Killian DN, Mellon JJA et al. Bronchial reactivity to inhaled histamine: a method and clinical service. Clin Allergy 1977; 7: 235– 243. 15 Chai H, Farr RS, Froelich LA et al. Standardization of bronchial inhalation challenge procedure. J Allergy Clin Immun 1975; 56: 322– 327. 16 Balzano G, Schiano M, Cocco G. Me-far dosimeter in bronchial provocation testing with pharmacological agents. Respir New Bull 1984; 26: 3– 5. 17 Frolund L, Svendsen NG, Nielsen NH et al. Bronchial allergen challenge: comparison between two different methods of provocation. Clin Allergy 1987; 17: 439– 448. 18 Pinto Mendes JA, Heureiro AC, Todo-Bom AM et al. Bronchial tests with antigen in solution and in powder form. In: Respiratory allergy. Clin immunol VII. G Melillo, PS Norman, G Marone, ed. New York: Marcel Dekker Inc. 1990, 215– 219. 19 Siergiejko Z, Chyrek-Borowska S. The evaluation of the specific bronchial provocation test with powder allergens and allergen solution in allergic asthma. J Aerosol Med 1993; 6(4) 1287– 294. 20 Metzger WJ, Nugent R, Moseley P et al. Methods for bronchoalveolar lavage in asthmatic patients following bronchoprovocation and local antigen challenge. Chest 1985; 87: 165– 175. 21 Metzger WJ, Zavola D, Richerson HB. Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs. Am Rev Respir Dis 1987; 135: 430. 22 Richerson HR, Metzger WJ, Hunninghake GW. Experimental models of bronchial asthma in man and in the rabbit. In: AB Kay, ed. Asthma - clinical pharmacology and therapeutical progress. Oxford: Blackwell Scientific Publishers, 1986: 23– 32. 23 Henning R, Lanke E, Muller S et al. A method of intrasegmental allergen provocation followed by bronchoalveolar lavage in patients with pollen asthma. J Asthma 1990; 28(4): 251– 254. 24 Liu MC, Hubbard WC, Proud D et al. Immediate and late inflammatory responses to rag weed antigen challenge of peripheral airways in allergic asthmatics: cellular, mediator and permeability changes. Am Rev Respir Dis 1991; 144: 51– 58. 25 Bernstein D, Ploysongsang Y, Mittman R, Piyamahunt A, Bernstein I. The relationship between airway responsiveness measured before and after allergen-induced late asthmatic response. Chest 1992; 101(2): 437– 41. 26 Clement J, Landser F, Van de Woestijne K. Total resistance and reactance in patients with respiratory complaints with and without airways obstruction. Chest 1983; 2: 215– 220. 27 Gimeno F, Van der Weele L, Koeter G, de Monchy J, Altena R. Variability of forced oscillation (Siemens Siregnost FD 5) measurements of total respiratory resistance in patients and healthy subjects. Ann Allergy 1993; 71: 56– 60. 28 Weller MS, Weller FR, Rijssenbeek-Nouwens LHM, de Monchy JGR. Time course of the later bronchial reaction after allergen challenge. Allergy 1992; 47: 19. 29 Durham SR., Kay AB. Eosinophils, hyperreactivity and late-phase asthmatic reactions. Clin Allegy 1985; 15: 411– 18. 30 Flick W, Sedwick J, Busse W. The appearance of hypodense eosinophils in antigen-dependent late-phase asthma. Am Rev Respir Dis 1989; 139: 1401– 1406. 31 Van Bever H, Moens MM, Bridts CH et al. Effect of a bronchial provocation test with house-dust mite on blood eosinophilia, eosinophil cationic protein, soluble inter-leukin-2 receptor, and interleukin-6 in asthmatic children. Allergy 1993; 48(6): 443– 9. 32 Metzger W, Richerson H, Wasserman S. Generation and partial characterization of eosinophil chemotactic activity and neutrophil chemotactic activity during early and late-phase asthmatic response. J Allergy Clin Immunol 1986; 78: 282– 90. 33 Hakansson L, Rak S, Dahl R, Venge P. The formation of eosinophil and neutrophil chemotactic activity during a pollen season and after allergen challenge. J Allergy Clin Immunol 1989; 83: 933– 939. 34 de Monchy J, Keyzer J, Kauffman H, Beaumont F, de Vries K. Histamine in late asthmatic reactions following house dust mite inhalations. Agent Actions 1985; 16: 252– 255. 35 Holgate S, Wilson J, Howarth FP. Insights into airway inflammation by endobronchial biopsy. Am Rev Respir Dis 1992; 145: S2– S6. 36 Hamid Q, Azzawi M, Ying S et al. Expression of messenger RNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 1991; 87(5): 1541– 1546. 37 Broide DH, Lotz M, Cuomo AJ, Cobum DA, Federman EC, Wasserman SI. Cytokines in symptomatic asthma airways. J Allergy Clin Immunol 1992; 89: 958– 67. 38 Robinson D, Hamid Q, Bentley A, Ying S, Kay A, Durham S. Activation of CD4+ T cells, increased Th2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol 1993; 92: 313– 24. 39 Von Essen S, Robbins R, Spurzem J, Thompson A, McGranaghan S, Rennard S. Bronchoscopy with bronchoalveolar lavages causes neutrophil recruitment to the lower respiratory tract. Am Rev Respir Dis 1991; 141: 848– 854. 40 Clinical guidelines and indications for bronchoalveolar lavage (BAL): Report of the European Society of Pneumology Task Group on BAL. Eur Respir J 1990; 3(8): 937– 76. 1 Melillo G, Cocco G, D'Amato G. Bronchial provocation tests in etiologic diagnosis of asthma. Broncho-pneumolo-gie 1979; 29: 329– 336. 2 SEPCR Working Group “Bronchial Hyperreactivity. Guidelines for standardization of bronchial challenges with (nonspecific) bronchoconstricting agents Bull Eur Physiopathol Respir 1983; 19: 495– 514. 3 Hargreave FE, Dolovich J, Boulet LP. Inhalation provocation tests Semin Respir Med 1983; 42: 24– 8. 4 Burge PS. Aerosol challenge in lung disease. In: SW Clarke, D Paiva, ed. Aerosols and the lung. London: Butterworths, 1984: 225– 240. 5 Melillo G. Allergen inhalation challenge with a micronized freeze fried extract administered by a powder inhaler. In: G Melillo, PS Norman, G Marone, ed. Respiratory allergy, Clinical immunology, V 2. New York: M. Dekker, 1990;23: 207– 213. 6 Herxheimer H. Bronchial hypersensitization and hypo-sensitization in man. Int Arch Allergy Immunol 1951; 2: 40– 44. 7 Cormell JT. Quantitative intranasal pollen challenges. III. The priming effect in allergic rhinitis. J Allergy 1969; 43: 33– 37. 8 Kelly JF, Fish JE, Peterman VI. Effect of environmental exposure on bronchial sensitivity to antigen. Int Arch Allergy Immunol 1979; 59: 130– 134. 1 Altmann DG, Bland JM. Measurement in medicine: The analysis of methods comparison studies. Statistician 1983; 32: 307– 17. 2 Bland JM, Altmann DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 307– 10. 3 Bruce CA, Rosenthal RR, Lichtenstein LM, Norman PS. Diagnostic tests in ragweed-allergic asthma. A comparison of direct skin-tests, leukocyte histamine release, and quantitative bronchial challenge. J Allergy Clin Immunol 1974; 53: 230– 9. 4 Cartier A, Thomson NC, Frith PA, Roberts R, Tech M, Hargreave FE. Allergen-induced increase in bronchial responsiveness to histamine: relationship to the late asthmatic response and change in airway caliber. J Allergy Clin Immunol 1982; 70: 170– 77. 5 Chinn S. Repeatability and method comparison. Thorax 1991; 46: 454– 56.
Referência(s)